05Nov 2023
Utility of serum β2-microglobulin for prediction of kidney outcome in patients with biopsy-proven diabetic nephropathy

Utility of serum β2-microglobulin for prediction of kidney outcome in patients with biopsy-proven diabetic nephropathy

This study explores the predictive value of serum β2-microglobulin (β2-MG) for kidney failure with replacement therapy (KFRT) in diabetic nephropathy (DN) patients. Analyzing biopsy-proven DN cases, elevated serum β2-MG levels were independently associated with a higher KFRT incidence, even after adjusting for known risk factors. Incorporating β2-MG improved prediction performance for KFRT, suggesting its utility alongside serum creatinine in DN management.

  • #endo-diabetology

Like

Save

Share